305
Views
3
CrossRef citations to date
0
Altmetric
Original Articles

Inhibiting effect of oleocanthal on neuroblastoma cancer cell proliferation in culture

ORCID Icon, , , , & ORCID Icon

References

  • Akl MR, Ayoub NM, Mohyeldin MM, Busnena BA, Foudah AI, Liu YY, Sayed KA. (2014). Olive phenolics as c-Met inhibitors: oleocanthal attenuates cell proliferation, invasiveness, and tumor growth in breast cancer models. PLoS One. 21; 95:e97622.
  • Beauchamp GK, Keast RSJ, Morel D, Lin J, Pika J, Han, Q, Lee CH, Smith AB, Breslin PAS. (2005). Phytochemistry: ibuprofen-like activity in extra-virgin olive oil. Nature. 437:45–46.
  • Bhaskar B, Mekala NK, Baadhe RR, Rao PS. (2014). Role of signaling pathways in mesenchymal stem cell differentiation. Curr Stem Cell Res Ther. 96:508–512.
  • Cargnello M, Roux PP. (2011). Activation and function of the MAPKs and their substrates, the MAPK-activated protein kinases. Microbiol Mol Biol Rev. 751:50–83.
  • Cusimano A, Balasus D, Azzolina A, Augello G, Emma MR, Di Sano C, Gramignoli R, Strom SC, McCubrey JA, Montalto G, Cervello M. (2017). Oleocanthal exerts antitumor effects on human liver and colon cancer cells through ROS generation. Int J Oncol. 512:533–544.
  • Elnagar AY, Sylvester PW, El Sayed KA. (2011) Oleocanthal as a c-Met inhibitor for the control of metastatic breast and prostate cancers. Planta Med. 77:1013–1019.
  • Geula C, Wu CK, Saroff D, Lorenzo A, Yuan M, Yankner BA. (1998) Aging renders the brain vulnerable to amyloid beta-protein neurotoxicity. Nat Med. 47:827–831.
  • Goldsby RE, Matthay KK. (2004). Neuroblastoma: evolving therapies for a disease with many faces. Ped Drugs. 62:107–122.
  • Gorrini C, Harris IS,Mak TW. (2013). Modulation of oxidative stress as an anticancer strategy. Nat Rev Drug Discov. 12:931–947.
  • Gross RE, Farber S, Martin LW. (1959) Neuroblastoma sympatheticum: a study and report of 217 cases. Pediatrics. 23:1179–1191.
  • Gu Y, Wang J, Peng L. (2017). (-)-Oleocanthal exerts anti-melanoma activities and inhibits STAT3 signaling pathway. Oncol Rep. 371:483–491.
  • Khanfar MA, Bardaweel SK, Akl MR, El Sayed KA. (2015) Olive oil-derived oleocanthal as potent ınhibitor of mammalian target of rapamycin: biological evaluation and molecular modeling studies. Phytother Res. 2911:1776–1782.
  • Kumar V, Abbas AK, Fausto N. (2005). Robbins and Cotran pathologic basis of disease. 7th ed., Elsevier Saunders. Philadelphia, PA. p. 295–505.
  • Li W, Sperry JB, Crowe A, Trojanowski JQ, Smith AB, Lee VM. (2009). Inhibition of tau fibrillization by oleocanthal via reaction with the amino groups of tau. J. Neurochem. 110:1339–1351.
  • Li Y, Zhuo B, Yin Y, Han T, Li S, Li Z, Wang J. (2017) Anti-cancer effect of oncolytic adenovirus-armed shRNA targeting MYCN gene on doxorubicin-resistant neuroblastoma cells. Biochem Biophys Res Commun. 491:134–139 .
  • Margarucci L, Monti MC, Cassiano C, Mozzicafreddo M, Angeletti M, Riccio R, Tosco A, Casapullo A. (2013) Chemical proteomics-driven discovery of oleocanthal as an Hsp90 inhibitor. Chem Commun Camb. 49:5844–5846.
  • Mete M, Aydemir I, Ünsal ÜÜ, Duransoy YK, Tuğlu Mİ, Selçuki M. (2016). Neuroprotective effects of bone marrow-derived mesenchymal stem cells and conditioned medium in mechanically injured neuroblastoma cells. Turk J Med Sci. 46:1900–1907.
  • Park S, Jung HH, Park YH, Ahn JS, Im YH. (2011) ERK/MAPK pathways play critical roles in EGFR ligands-induced MMP1 expression. Biochem Biophys Res Commun. 407:680–686.
  • Pitt J, Roth W, Lacor P, Smith AB 3rd, Blankenship M, Velasco P, De Felice F, Breslin P, Klein WL. (2009) Alzheimer’s-associated abeta oligomers show altered structure, immunoreactivity and synaptotoxicity with low doses of oleocanthal. Toxicol Appl Pharmacol. 2402:189–197.
  • Pourheydar B, Soleimani Asl S, Azimzadeh M, Rezaei Moghadam A, Marzban A, Mehdizadeh M. (2016) Neuroprotective effects of bone marrow mesenchymal stem cells on bilateral common carotid arteries occlusion model of cerebral ischemia in rat. Behav Neurol. 2016:2964712. Epub 2016 Oct 25.
  • Rosso SB, Inestrosa NC. (2013). WNT signaling in neuronal maturation and synaptogenesis. Front Cell Neurosci. 7:103.1–11. doi:10.3389/fncel.2013.00103.
  • Salehi H, Amirpour N, Niapour A, Razavi S. (2016). An overview of neural differentiation potential of human adipose derived stem cells. Stem Cell Rev. 121:26–41.
  • Schroeder H, Wacher J, Larsson H, Rosthoej S, Rechnitzer C, Petersen BL, Carlsen NL. (2009). Unchanged incidence and increased survival in children with neuroblastoma in Denmark 1981-2000: a population-based study. Br J Cancer. 100:853–857.
  • Scotece M, Gomez R, Conde J, Lopez V, Gomez Rein J, Lago F, Smith AB 3rd, Gualillo O. (2013). Oleocanthal inhibits proliferation and MIP-1a expression in human multiple myeloma cells. Curr Med Chem. 20:2467–2475.
  • Sharma RK, Candelario-Jalil E, Feineis D, Bringmann G, Fiebich BL, Akundi RS. (2017). 1-Trichloromethyl-1,2,3,4-tetrahydro-beta-carboline TaClo) alters cell cycle progression in human neuroblastoma cell lines. Neurotox Res. 324:649–660.
  • Spitz R, Hero B, Westermann F, Ernestus K, Schwab M, Berthold F. (2002) Fluorescence in situ hybridization analyses of chromosome band 1p36 in neuroblastoma detect two classes of alterations. Genes Chrom Cancer. 343:299–305.
  • Takahashi N, Koyama S, Hasegawa S, Yamasaki M, Imai M. (2017) Anticancer efficacy of p-dodecylaminophenol against high-risk and refractory neuroblastoma cells in vitro and in vivo. Bioorg Med Chem Lett. 27:4664–4672.
  • Vural K, Tuğlu MI. (2011) Neurotoxic effect of statins on mouse neuroblastoma NB2a cell line. Eur Rev Med Pharmacol Sci.159:985–991.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.